SCHEMBL2297897

SCHEMBL2297897

COCOCCCCCCCCCCc1nc(-n2c(C)ccc2C)nc(C)c1OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 6/20 0.33
TSHR P16473 4/20 0.33
CYP3A4 P08684 4/20 0.33
MAPK1 P28482 1/20 0.33
BCHE P06276 2/20 0.32
CYP2C19 P33261 4/20 0.32
LMNA P02545 3/20 0.32
ALDH1A1 P00352 3/20 0.32
CYP2C9 P11712 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
NPC1 O15118 2/20 0.32
PKM P14618 1/20 0.32
RAB9A P51151 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ATP4A P20648 1/20 0.31
ATP4B P51164 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15306017 0.92 CYP1A2 (0.35) L3MBTL1CYP1A2TSHRCYP3A4MAPK1
SCHEMBL2300307 0.92 L3MBTL1 (0.42) L3MBTL1TDP1CYP1A2TSHRCYP3A4
SCHEMBL2303798 0.85 BCHE (0.39) L3MBTL1TSHRBCHESMN1; SMN2ATP4A
SCHEMBL2303764 0.85 BCHE (0.39) L3MBTL1TSHRBCHESMN1; SMN2ATP4A
SCHEMBL2300142 0.84 TSHR (0.38) L3MBTL1TDP1CYP1A2TSHRCYP3A4
SCHEMBL2235660 0.83 L3MBTL1 (0.39) L3MBTL1TDP1CYP1A2TSHRCYP3A4
SCHEMBL2238461 0.83 L3MBTL1 (0.42) L3MBTL1TDP1CYP1A2TSHRCYP3A4
SCHEMBL2234757 0.83 DHFR (0.40) L3MBTL1TDP1TSHRSMN1; SMN2STAT3
SCHEMBL2296237 0.83 TDP1 (0.36) L3MBTL1TDP1CYP1A2TSHRCYP3A4
SCHEMBL15306028 0.81 TSHR (0.40) L3MBTL1TDP1CYP1A2TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536690-B1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE UNIV ARIZONA (US) 2018-08-08 EP disclosed
US-8952025-B2 Multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-02-10 US disclosed
US-8952025-B2 Multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-02-10 US disclosed
US-20130267546-A1 Multifunctional Radical Quenchers and Their Uses Arizona Board of Regents, a body corporate of the State of Arizona acting for and on behalf of Ari (US) 2013-10-10 US disclosed
US-20130267546-A1 Multifunctional Radical Quenchers and Their Uses Arizona Board of Regents, a body corporate of the State of Arizona acting for and on behalf of Ari (US) 2013-10-10 US disclosed
EP-2536690-A1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE Arizona Board Of Regents (US) 2012-12-26 EP disclosed
WO-2011103536-A1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE ARIZONA BOARD OF REGENTS (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267546-A1 Multifunctional Radical Quenchers and Their Uses SQOR, GSR, GPX4 L3MBTL1 2443/4885TDP1 752/4885CYP1A2 537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.